Mahmoud Mohamed Bahgat

11PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technologyMedical molecular engineering of nucleic acids and proteinsClinical chemistry (incl. diagnostics)Colloid and surface chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 24, 2026
Correction to: Chemotherapy of breast cancer cells alters susceptibility to complement‑mediated opsonization and killing.

Mohamed Hassan Nasraa, Mahmoud Mohamed Bahgat, Michael Kirschfinik

|Jun 19, 2025
Chemotherapy of breast cancer cells alters susceptibility to complement-mediated opsonization and killing.

Mohamed Hassan Nasraa, Mahmoud Mohamed Bahgat, Michael Kirschfinik

|May 31, 2024
Production of Disinfective Coating Layer to Facial Masks Supplemented with Camellia sinensis Extract.

Dina Nadeem Abd-Elshafy, Heba Abdallah, Rola Nadeem

|Jan 24, 2024
Analysis of the SARS-CoV-2 nsp12 P323L/A529V mutations: coeffect in the transiently peaking lineage C.36.3 on protein structure and response to treatment in Egyptian records.

Dina N Abd-Elshafy, Rola Nadeem, Mohamed H Nasraa

|Nov 30, 2023
Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort.

Mahmoud Mohamed Bahgat, Mohamed Hassan Nasraa, Rola Nadeem

Pageof 2